In furtherance to its intimation dated 11th June, 2024 informing details about the 4th AGM of the Company to be held on Friday, 26th July, 2024 at 3:00 pm (IST) through Video Conferencing / Other Audio Visual Means and pursuant to Regulations 34(1) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Piramal Pharma has submitted the Annual Report of the Company for the financial year 2023-24 including the Business Responsibility & Sustainability Report and the Notice convening AGM. The said Annual Report along with the Notice of AGM is also available on the website of the Company under the ‘Annual Reports’ tab at https://www.piramalpharma.com/financial-reports.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: